Results 1 - 10
of
30
Hypoxia and adipose tissue function and dysfunction in obesity
- Physiol Rev
, 2013
"... Rev 93: 1–21, 2013; doi:10.1152/physrev.00017.2012.—The rise in the incidence of obesity has led to a major interest in the biology of white adipose tissue. The tissue is a major endocrine and signaling organ, with adipocytes, the characteristic cell type, secreting a multiplicity of protein factors ..."
Abstract
-
Cited by 21 (0 self)
- Add to MetaCart
(Show Context)
Rev 93: 1–21, 2013; doi:10.1152/physrev.00017.2012.—The rise in the incidence of obesity has led to a major interest in the biology of white adipose tissue. The tissue is a major endocrine and signaling organ, with adipocytes, the characteristic cell type, secreting a multiplicity of protein factors, the adipokines. Increases in the secretion of a number of adipokines occur in obesity, underpinning inflammation in white adipose tissue and the development of obesity-associated diseases. There is substantial evidence, particularly from animal studies, that hypoxia develops in adipose tissue as the tissue mass expands, and the reduction in PO2 is considered to underlie the inflammatory response. Exposure of white adipocytes to hypoxic conditions in culture induces changes in the expression of 1,000 genes. The secretion of a number of inflammation-related adipokines is upregulated by hypoxia, and there is a switch from oxidative metabolism to anaerobic glycolysis. Glucose utilization is increased in hypoxic adipocytes with corresponding increases in lactate production. Importantly, hypoxia induces insulin resistance in fat cells and leads to the development of adipose tissue fibrosis. Many of the responses of adipocytes to hypoxia are initiated at PO2 levels above the normal physiological range for adipose tissue. The other cell types within the tissue also respond to hypoxia, with the differentiation of
Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes Findings From the Look AHEAD Study
"... Objective—Plasminogen activator inhibitor-1 (PAI-1) production by adipose tissue is increased in obesity, and its circulating levels are high in type 2 diabetes. PAI-1 increases cardiovascular risk by favoring clot stability, interfering with vascular remodeling, or both. We investigated in obese di ..."
Abstract
-
Cited by 1 (0 self)
- Add to MetaCart
Objective—Plasminogen activator inhibitor-1 (PAI-1) production by adipose tissue is increased in obesity, and its circulating levels are high in type 2 diabetes. PAI-1 increases cardiovascular risk by favoring clot stability, interfering with vascular remodeling, or both. We investigated in obese diabetic persons whether an intensive lifestyle intervention for weight loss (ILI) would decrease PAI-1 levels independently of weight loss and whether PAI-1 reduction would be associated with changes in fibrinogen, an acute phase reactant, or fibrin fragment D-dimer (D-dimer), a marker of ambient coagulation balance. Methods and Results—We examined 1-year changes in PAI-1, D-dimer, and fibrinogen levels; adiposity; fitness; glucose; and lipid control with ILI in 1817 participants from Look AHEAD, a randomized trial investigating the effects of ILI, compared with usual care, on cardiovascular events in overweight or obese diabetic persons. Median PAI-1 levels decreased 29 % with ILI and 2.5 % with usual care (P0.0001). Improvements in fitness, glucose control, and high-density lipoprotein cholesterol were associated with decreased PAI-1, independently of weight loss (P0.03 for fitness, P0.0001 for others). Fibrinogen and D-dimer remained unchanged. Conclusion—Reductions in PAI-1 levels with ILI in obese diabetic individuals may reflect an improvement in adipose tissue health that could affect cardiovascular risk without changing fibrinogen or D-dimer levels.
Alterations in adipose tissue during critical illness: an adaptive and protective response (abstract)?
- International Symposium on Intensive Care Medicine,
, 2010
"... ..."
(Show Context)
Edinburgh Research Explorer Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11-Hydroxysteroid
"... Publisher's PDF, also known as Version of record ..."
(Show Context)
GENETIC AND NUTRITIONAL STUDIES TO ELUCIDATE THE ROLE OF ADIPOSE TISSUE IN THE PATHOGENESIS OF METABOLIC SYNDROME
, 2011
"... Genetic and nutritional studies to elucidate the role of adipose tissue in the pathogenesis of metabolic syndrome ..."
Abstract
- Add to MetaCart
(Show Context)
Genetic and nutritional studies to elucidate the role of adipose tissue in the pathogenesis of metabolic syndrome
unknown title
, 2013
"... Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia ..."
Abstract
- Add to MetaCart
(Show Context)
Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia
Review Hypoxia, Oxidative Stress and Fat
"... www.mdpi.com/journal/biomolecules/ ..."
(Show Context)
Article ID 952916, 9 pages Town, Cape Town 8001, South Africa 4 Health Impact Assessment, Western Cape Department of Health
"... Women of African ancestry, particularly those living in industrialized countries, experience a disproportionately higher prevalence of type 2 diabetes (T2D) compared to their white counterparts. Similarly, obesity and insulin resistance, which are major risk factors for T2D, are greater in black co ..."
Abstract
- Add to MetaCart
(Show Context)
Women of African ancestry, particularly those living in industrialized countries, experience a disproportionately higher prevalence of type 2 diabetes (T2D) compared to their white counterparts. Similarly, obesity and insulin resistance, which are major risk factors for T2D, are greater in black compared to white women. e exact mechanisms underlying these phenomena are not known. is paper will focus on the role of adipose tissue biology. Firstly, the characteristic body fat distribution of women of African ancestry will be discussed, followed by the depot-speci�c associations with insulin resistance. Factors involved in adipose tissue biology and their relation to insulin sensitivity will then be explored, including the role of sex hormones, glucocorticoid metabolism, lipolysis and adipogenesis, and their conse�uent effects on adipose tissue hypoxia, oxidative stress, and in�ammation. Finally the role of ectopic fat deposition will be discussed. e paper proposes directions for future research, in particular highlighting the need for longitudinal and/or intervention studies to better understand the mechanisms underlying the high prevalence of insulin resistance and T2D in women of African ancestry.
ORIGINAL ARTICLE Short-Term Overfeeding May Induce Peripheral Insulin Resistance Without Altering Subcutaneous Adipose Tissue Macrophages in Humans
"... OBJECTIVE—Chronic low-grade inflammation is a feature of obesity and is postulated to be causal in the development of insulin resistance and type 2 diabetes. The aim of this study was to assess whether overfeeding induces peripheral insulin resistance in lean and overweight humans, and, if so, wheth ..."
Abstract
- Add to MetaCart
(Show Context)
OBJECTIVE—Chronic low-grade inflammation is a feature of obesity and is postulated to be causal in the development of insulin resistance and type 2 diabetes. The aim of this study was to assess whether overfeeding induces peripheral insulin resistance in lean and overweight humans, and, if so, whether it is associated with increased systemic and adipose tissue inflammation. RESEARCH DESIGN AND METHODS—Thirty-six healthy individuals undertook 28 days of overfeeding by �1,250 kcal/day (45 % fat). Weight, body composition, insulin sensitivity (hyperinsulinemic-euglycemic clamp), serum and gene expression of inflammation markers, immune cell activation, fat cell size, macrophage and T-cell numbers in abdominal subcutaneous adipose tissue (flow cytometry and immunohistochemistry) were assessed at baseline and after 28 days.
Winning a Won Game: Caffeine Panacea for Obesity Syndemic
"... Abstract: Over the past decades, chronic sleep reduction and a concurrent development of obesity have been recognized as a common problem in the industrialized world. Among its numerous untoward effects, there is a possibility that insomnia is also a major contributor to obesity. This attribution po ..."
Abstract
- Add to MetaCart
(Show Context)
Abstract: Over the past decades, chronic sleep reduction and a concurrent development of obesity have been recognized as a common problem in the industrialized world. Among its numerous untoward effects, there is a possibility that insomnia is also a major contributor to obesity. This attribution poses a problem for caffeine, an inexpensive, “natural ” agent that is purported to improve a number of conditions and is often indicated in a long-term pharmacotherapy in the context of weight management. The present study used the “common target ” approach by exploring the tentative shared molecular networks of insomnia and adiposity. It discusses caffeine targets beyond those associated with adenosine signaling machinery, phosphodiesterases, and calcium release channels. Here, we provide a view suggesting that caffeine could exert some of its effects by acting on several signaling complexes composed of HIF-1�/VEGF/IL-8 along with NO, TNF-�, IL1, and GHRH, among others. Although the relevance of these targets to the reported therapeutic effects of caffeine has remained difficult to assess, the utilization of caffeine efficacies and potencies recommend its repurposing for development of novel therapeutic approaches. Among indications mentioned, are neuroprotective, nootropic, antioxidant, proliferative, anti-fibrotic, and anti-angiogenic that appear under a variety of dissimilar diagnostic labels comorbid with obesity. In the absence of safe and efficacious antiobesity agents, caffeine remains an attractive adjuvant.